| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |